Top Markets
Coin of the day
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
Classificação em ações #32090
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Preço da ação
$0.21483059
Última sincronização: 2024-05-07
Valor de mercado
$11.13M
Variação (1 dia)
0.34%
Variação (1 ano)
0.00%
País
CA
Negociar Antibe Therapeutics Inc. (ATE)

Categoria

Preço ATE com a capitalização de mercado de B
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
ATE
$0.21483059
Capitalização de mercado de Antibe Therapeutics Inc.(ATE)
Valor de mercado: $11.13M
Em August 2026, Antibe Therapeutics Inc. tem uma capitalização de mercado de $11.13M. Isso faz com que Antibe Therapeutics Inc. seja a 32090th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Antibe Therapeutics Inc. de 2013 a 2026
ATE comparado com o topo de 5 mais populares stocks
Preço para ATE Ativo B Capitalização de mercado de B Resultados
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$105,363 $11.13M
$5.460T +49,044,735.68%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$86,632.75 $11.13M
$4.489T +40,325,975.22%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$79,906.01 $11.13M
$4.141T +37,194,795.68%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$68,861.34 $11.13M
$3.569T +32,053,685.74%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$53,993.05 $11.13M
$2.798T +25,132,751.91%